B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes

doi:10.1084/jem.165.1.157

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Hu-Li, J.
	Articles by Paul, W. E.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Hu-Li, J.
	Articles by Paul, W. E.


Social Bookmarking

	What's this?

ARTICLES

B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes

J Hu-Li, EM Shevach, J Mizuguchi, J Ohara, T Mosmann and WE Paul

Resting T cells proliferate in response to B cell stimulatory factor 1 (BSF-1; interleukin 4) plus phorbol myristate acetate (PMA). This response is obtained with highly purified T cells and is density independent, suggesting that accessory cells are not required. Both L3T4+ and Lyt-2+ T cells respond to BSF-1 plus PMA. Although BSF-1 alone does not cause T cell proliferation, it maintains the viability of small, dense T cells, indicating that it acts on resting T cells. Furthermore, BSF-1 is required early in the proliferative response of resting T cells to BSF-1 plus PMA, further supporting the concept that it acts on G0 or early G1 cells. However, BSF-1 is also needed late in the first round of division of T cells stimulated with BSF-1 plus PMA. Removing BSF-1 at 24 h of stimulation prevents entry into S phase. These results indicate that BSF-1 is involved in both the induction of competence and in the progression phases of T cell division.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Passerini, L., Allan, S. E., Battaglia, M., Di Nunzio, S., Alstad, A. N., Levings, M. K., Roncarolo, M. G., Bacchetta, R. (2008). STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells. Int Immunol 20: 421-431 [Abstract] [Full Text]
Osusky, M., Teschke, L., Wang, X., Wong, K., Buckley, J. T. (2008). A Chimera of Interleukin 2 and a Binding Variant of Aerolysin Is Selectively Toxic to Cells Displaying the Interleukin 2 Receptor. J. Biol. Chem. 283: 1572-1579 [Abstract] [Full Text]
Landi, A., Babiuk, L. A., van Drunen Littel-van den Hurk, S. (2007). High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer. J. Leukoc. Biol. 82: 849-860 [Abstract] [Full Text]
Wilson, E. H., Zaph, C., Mohrs, M., Welcher, A., Siu, J., Artis, D., Hunter, C. A. (2006). B7RP-1-ICOS Interactions Are Required for Optimal Infection-Induced Expansion of CD4+ Th1 and Th2 Responses. J. Immunol. 177: 2365-2372 [Abstract] [Full Text]
Okada, H., Attanucci, J., Giezeman-Smits, K. M., Brissette-Storkus, C., Fellows, W. K., Gambotto, A., Pollack, I. F., Pogue-Geile, K., Lotze, M. T., Bozik, M. E., Chambers, W. H. (2001). Immunization with an Antigen Identified by Cytokine Tumor Vaccine-assisted SEREX (CAS) Suppressed Growth of the Rat 9L Glioma in Vivo. Cancer Res. 61: 2625-2631 [Abstract] [Full Text]
Mora, A. L., Youn, J., Keegan, A. D., Boothby, M. (2001). NF-{{kappa}}B/Rel Participation in the Lymphokine-Dependent Proliferation of T Lymphoid Cells. J. Immunol. 166: 2218-2227 [Abstract] [Full Text]
Kruse, S., Forster, J., Kuehr, J., Deichmann, K. A. (1999). Characterization of the membrane-bound and a soluble form of human IL-4 receptor {alpha} produced by alternative splicing. Int Immunol 11: 1965-1970 [Abstract] [Full Text]
Aung, S., Tang, Y.-W., Graham, B. S. (1999). Interleukin-4 Diminishes CD8+ Respiratory Syncytial Virus-Specific Cytotoxic T-Lymphocyte Activity In Vivo. J. Virol. 73: 8944-8949 [Abstract] [Full Text]
Golumbek, P., Lazenby, A., Levitsky, H., Jaffee, L., Karasuyama, H, Baker, M, Pardoll, D. (1991). Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254: 713-716 [Abstract]